华邦健康：子公司获得药品注册证书

Core Viewpoint - Huabang Health (002004) announced that its wholly-owned subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd., has received the drug registration certificates for Fusidic Acid Cream and Fluticasone Propionate Cream from the National Medical Products Administration, marking a significant expansion in the company's dermatological product pipeline [1] Summary by Categories Product Approval - The company has obtained approval for Fusidic Acid Cream, which is primarily used to treat skin infections caused by Staphylococcus and Streptococcus [1] - Fluticasone Propionate Cream is approved for use in adults and children to alleviate inflammation and itching associated with skin diseases [1] Market Impact - The approval of these products enhances the company's offerings in the dermatology sector, potentially increasing its market share and revenue streams [1]